Ken Griffin Personalis, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1.19 - $6.34 $75,922 - $404,492	63,800 New	63,800 $343,000
Q1 2024 May 15, 2024	BUY	$1.15 - $2.19 $575 - $1,095	500 New	500 $0
Q3 2023 Nov 14, 2023	SELL	$1.19 - $2.36 $2,975 - $5,900	-2,500 Reduced 71.43%	1,000 $1,000
Q2 2023 Aug 14, 2023	SELL	$1.8 - $3.19 $9,900 - $17,545	-5,500 Reduced 61.11%	3,500 $6,000
Q1 2023 May 15, 2023	SELL	$2.01 - $4.17 $12,863 - $26,688	-6,400 Reduced 41.56%	9,000 $24,000
Q4 2022 Feb 14, 2023	BUY	$1.78 - $3.64 $4,984 - $10,192	2,800 Added 22.22%	15,400 $30,000
Q3 2022 Nov 14, 2022	BUY	$2.89 - $5.32 $36,414 - $67,032	12,600 New	12,600 $37,000

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $264M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.